These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 20714117)

  • 1. Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.
    Ito M; Masumi A; Mochida K; Kukihara H; Moriishi K; Matsuura Y; Yamaguchi K; Mizuochi T
    J Innate Immun; 2010; 2(6):607-17. PubMed ID: 20714117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
    Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
    J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.
    Paz S; Sun Q; Nakhaei P; Romieu-Mourez R; Goubau D; Julkunen I; Lin R; Hiscott J
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):17-28. PubMed ID: 16914100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon.
    Fensterl V; Grotheer D; Berk I; Schlemminger S; Vallbracht A; Dotzauer A
    J Virol; 2005 Sep; 79(17):10968-77. PubMed ID: 16103148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
    Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
    EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced RIG-I expression is mediated by interferon regulatory factor-2 in peripheral blood B cells from hepatitis C virus-infected patients.
    Masumi A; Ito M; Mochida K; Hamaguchi I; Mizukami T; Momose H; Kuramitsu M; Tsuruhara M; Takizawa K; Kato A; Yamaguchi K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1623-8. PubMed ID: 20034464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM11 negatively regulates IFNβ production and antiviral activity by targeting TBK1.
    Lee Y; Song B; Park C; Kwon KS
    PLoS One; 2013; 8(5):e63255. PubMed ID: 23675467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
    Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
    J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Kinase MAP4K1 Inhibits Cytosolic RNA-Induced Antiviral Signaling by Promoting Proteasomal Degradation of TBK1/IKKε.
    He TS; Huang J; Chen T; Zhang Z; Cai K; Yu J; Xu LG
    Microbiol Spectr; 2021 Dec; 9(3):e0145821. PubMed ID: 34908452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of DDX3 expression by ginsenoside Rg3 through the Akt/p53 pathway activates the innate immune response via TBK1/IKKε/IRF3 signalling.
    Choi YJ; Kang LJ; Lee SG
    Curr Med Chem; 2014; 21(8):1050-60. PubMed ID: 24180280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein kinase IKKepsilon can inhibit HCV expression independently of IFN and its own expression is downregulated in HCV-infected livers.
    Vilasco M; Larrea E; Vitour D; Dabo S; Breiman A; Regnault B; Riezu JI; Eid P; Prieto J; Meurs EF
    Hepatology; 2006 Dec; 44(6):1635-47. PubMed ID: 17133498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
    Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
    Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation.
    Schröder M; Baran M; Bowie AG
    EMBO J; 2008 Aug; 27(15):2147-57. PubMed ID: 18636090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKε.
    Pythoud C; Rodrigo WW; Pasqual G; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
    J Virol; 2012 Aug; 86(15):7728-38. PubMed ID: 22532683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein.
    Jiang J; Tang H
    Protein Cell; 2010 Dec; 1(12):1106-17. PubMed ID: 21213104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.
    Unterholzner L; Sumner RP; Baran M; Ren H; Mansur DS; Bourke NM; Randow F; Smith GL; Bowie AG
    PLoS Pathog; 2011 Sep; 7(9):e1002247. PubMed ID: 21931555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of TBK1 and IKKepsilon in lipopolysaccharide-induced activation of the interferon response in primary human macrophages.
    Solis M; Romieu-Mourez R; Goubau D; Grandvaux N; Mesplede T; Julkunen I; Nardin A; Salcedo M; Hiscott J
    Eur J Immunol; 2007 Feb; 37(2):528-39. PubMed ID: 17236232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CXCL-8 (interleukin-8) induction by double-stranded RNA signaling pathways during hepatitis C virus infection.
    Wagoner J; Austin M; Green J; Imaizumi T; Casola A; Brasier A; Khabar KS; Wakita T; Gale M; Polyak SJ
    J Virol; 2007 Jan; 81(1):309-18. PubMed ID: 17035306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.
    Dansako H; Ikeda M; Kato N
    FEBS J; 2007 Aug; 274(16):4161-76. PubMed ID: 17651439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.